Search

Your search keyword '"Liu, Shouchun"' showing total 133 results

Search Constraints

Start Over You searched for: Author "Liu, Shouchun" Remove constraint Author: "Liu, Shouchun"
133 results on '"Liu, Shouchun"'

Search Results

10. Effect of yeast-Agastache rugosus complex on deodorization of tilapia based on gas chromatography ion mobility spectroscopy and partial least squares discriminant analysis.

14. Transmembrane domain helix packing stabilizes integrin aIIb beta 3 in the low affinity state

15. Data from Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate

16. Supplementary Data from Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate

17. Supplementary Data from A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity

20. A Probody T Cell–Engaging Bispecific Antibody Targeting EGFR and CD3 Inhibits Colon Cancer Growth with Limited Toxicity

21. Nonclinical Efficacy and Safety of CX-2029, an Anti-CD71 Probody–Drug Conjugate

23. Conditional PD-1/PD-L1 Probody Therapeutics Induce Comparable Antitumor Immunity but Reduced Systemic Toxicity Compared with Traditional Anti–PD-1/PD-L1 Agents

27. Comprehensive and quantifiable granularity: A novel model to measure agro-food traceability

28. The lymphoid cell surface receptor NTB-A: a novel monoclonal antibody target for leukaemia and lymphoma therapeutics

30. Abstract 213: Development of a probody-drug conjugate targeting EpCAM for the treatment of solid tumors

32. Abstract B116: Optimizing a CD71-targeting Probody drug conjugate (PDC) for activity in multiple solid tumor and lymphoma models and for tolerability in nonhuman primates

34. Abstract B103: A multi-analyte HPLC-MS/MS approach to assessing exposure of a Probody drug conjugate in preclinical studies

35. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

37. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two

38. Abstract 2975: Development of a probody drug conjugate (PDC) targeting CD71 for the treatment of solid tumors and lymphomas

40. Abstract C165: Development of a probody drug conjugate (PDC) against CD166 for the treatment of multiple cancers

45. Tumor-Specific Activation of an EGFR-Targeting Probody Enhances Therapeutic Index

46. Abstract 4570: Development of a proteolytically activatable EGFR Probody for cancer therapy.

47. Fish Protein Isolates Recovered from Silver Carp ( Hypophthalmichthys molitrix ) By-Products Using Alkaline pH Solubilization and Precipitation.

48. The First Propeller Domain of LRP6 Regulates Sensitivity to DKK1

49. R-Spondin Family Members Regulate the Wnt Pathway by a Common Mechanism

Catalog

Books, media, physical & digital resources